On June 15, Wistar hosted a hybrid event naming this year’s Ching Jer Chern Memorial Postdoctoral Fellow and bestowing the Ching Jer Chern Memorial Awards, honoring the commitment of the Chern family to advancing scientific careers. The ceremony was…
The Crystal Tearoom at the Wanamaker Building was an elegant backdrop for the Philadelphia Business Journal’s 2022 CFO of the Year Awards. Wistar Institute Chief Financial Officer (CFO) Joseph Trainor, CPA, was celebrated among top honorees represen…
PHILADELPHIA — (July 18, 2022) — Aging and age-related disorders pose a complex challenge to the biomedical research community. To better understand how senescence is regulated is of high significance to promote healthy aging and treat age-associate…
Dr. Ian Tietjen, Research Assistant Professor in the Montaner Lab, recently returned from Cameroon where he is collaborating with scientists who are developing a new drug discovery research facility that will study medicinal plants, natural product…
PHILADELPHIA — (July 13, 2022) — The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious diseases, is pleased to announce the appointment of Gelvina Rodriguez Stevenson, Esq., as vice president, genera…
PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery a…
This year, The Wistar Institute hosted the Annual Jonathan Lax Memorial Award Lecture virtually, bringing together HIV scientists and activists on a global stage. Celebrating 26 years of continuous HIV research collaboration, the event was streamed…
Philadelphia Business Journal senior health reporter John George hosted Taking on Cancer, a two-panel discussion that kicked off with perspectives from local research leaders at the helm of world-class research institutes and health care systems. It…
PHILADELPHIA — (June 21, 2022) — Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates. Therefore, new therapeutic options such as targeted therapy that boosts anti-tumo…
PHILADELPHIA — (JUNE 14, 2022) — The National Advisory Committee of the Pew Scholars Program in the Biomedical Sciences, has chosen Amelia Escolano, Ph.D., Assistant Professor in The Wistar Institute’s Vaccine & Immunotherapy Center, to join the…
